Occudo Quantitative Strategies’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
20,366
+3,878
+24% +$389K 0.1% 286
2025
Q4
$1.68M Buy
16,488
+12,506
+314% +$1.12M 0.11% 231
2025
Q3
$249K Sell
3,982
-5,166
-56% -$281K 0.03% 534
2025
Q2
$476K Buy
+9,148
New +$409K 0.05% 358

Other funds holding GH

Occudo Quantitative Strategies's GH Position: Q1 2026 in Review

Occudo Quantitative Strategies increased its Guardant Health (GH) stake by 24% in Q1 2026, buying an estimated $389K and bringing the position to 20,366 shares worth $1.77M. The position accounts for 0.1% of the portfolio, ranked #286.

Occudo Quantitative Strategies first reported a position in GH in Q2 2025 and has held it in 4 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Occudo Quantitative Strategies held 20,366 shares of Guardant Health worth $1.77M as of Q1 2026.
  • Occudo Quantitative Strategies bought 3,878 Guardant Health shares in Q1 2026, an estimated $389K.
  • Guardant Health made up 0.1% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #286 holding.
  • Occudo Quantitative Strategies first reported a position in Guardant Health in Q2 2025 and has held it in 4 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.